Tag: drug pricing

Medicare Proposes Fresh Cuts to Hospital 340B Drug Discount Program

Medicare has announced a new proposal to reduce payment rates for drugs dispensed under the 340B Drug Pricing Program, marking…

US Lawmakers Press Eli Lilly to Honor 340B Drug Discount Program for Hospitals

US lawmakers have formally requested HHS intervention to enforce Eli Lilly's participation in the 340B drug discount program, which requires…

Eli Lilly cuts 340B drug discounts to hospitals failing to report claims data

Eli Lilly has begun eliminating federally mandated drug price breaks to hospitals that failed to submit required claims data under…

Trump Administration Proposes Rule to Close Medicare Drug Price Negotiation Loophole

Trump administration proposes rule to close Medicare drug price negotiation loophole, potentially affecting 65 million beneficiaries. Policy targets pharmaceutical industry…

European Drug Pricing Pressures Rise as U.S. Policy Ripple Effects Spread Across Markets

European countries are adopting divergent pharmaceutical pricing policies, creating market complexity and affecting drug access. Healthcare systems face mounting pressure…

Trump Drug Pricing Deals Face First Test as New Medications Launch

President Trump's most-favored-nation drug pricing agreements with 17 pharmaceutical companies face their first real-world test as new medications launch. Healthcare…

Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network